Viewing Study NCT02534558


Ignite Creation Date: 2025-12-25 @ 12:26 AM
Ignite Modification Date: 2025-12-25 @ 10:32 PM
Study NCT ID: NCT02534558
Status: UNKNOWN
Last Update Posted: 2017-02-07
First Post: 2015-04-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pathomechanism of MicroRNA-29 in Shoulder Stiffness
Sponsor: Chang Gung Memorial Hospital
Organization:

Study Overview

Official Title: Pathomechanism of MicroRNA-29 in Shoulder Stiffness
Status: UNKNOWN
Status Verified Date: 2017-02
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The team integrates experimental analyses of clinical and basic medicine and transgenic mice models. miR-29a acts a potent protective factor against excessive fibrosis in myofibroblasts of subacromial bursa tissue. Gain of miR-29a stabilizes tendon and synovial tissue homeostasis that alleviates tissue stiffness and maintains function.
Detailed Description: Aims of first: The team will evaluate the associations among the mR-29a, miR-29b, miR-29c expression in subacromial bursa and subacromial fluid, incidence of shoulder stiffness, Constant scores, and VAS.

Aims of second: The team will isolate primary myofibroblast from subacromial bursa tissue as in vitro models and investigate the molecular events in the IL-1β modulation of miR-29a expression and the molecular mechanism underlying miR-29a inhibition of fibrotic matrix accumulation and apoptotic reactions in myofibroblast cultures.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
ChangGungMH REGISTRY ChangGungMH View